The abstract is read at the publisher; the summary is JClub's.
Population-based reference equations for plasma NfL and GFAP (n=5122) and amyloid biomarkers plus p-tau181 (n=5123) quantify age-linked increases and enable standardized Z-scores.
- Why it matters: Blood biomarker interpretation in neurodegenerative disease is confounded by age, sex, body-mass index, renal function, and assay-specific concentration differences across laboratories.
- What they did: Using generalized additive models in cognitively unimpaired participants from French CONSTANCES and Three-City cohorts, the study modeled NfL, GFAP, p-tau181, amyloid-{beta}40, amyloid-{beta}42, and ratios to generate individualized percentiles and Z-scores.
- The result: Expected NfL and GFAP rose by 2.6% and 2.2% per year from ages 40–80, and cross-calibration across methods/matrices showed intraclass correlation coefficients >0.90 while preserving disease-associated Z-score profiles.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.